Key statistics
On Friday, Femasys Inc (FEMY:NAQ) closed at 1.15, 295.87% above the 52 week low of 0.2905 set on Sep 21, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.20 |
---|---|
High | 1.20 |
Low | 1.13 |
Bid | 1.13 |
Offer | 1.19 |
Previous close | 1.17 |
Average volume | 155.59k |
---|---|
Shares outstanding | 22.23m |
Free float | 20.54m |
P/E (TTM) | -- |
Market cap | 25.57m USD |
EPS (TTM) | -0.8468 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Femasys Announces Infertility Clinic Customers from Coast to Coast
- Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish Market
- Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check
- Femasys to Exhibit at The Canadian Fertility and Andrology Society’s 70th Annual Meeting
- Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference
- Femasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment Solution
- Femasys Hosts Congresswoman Lucy McBath at Georgia Headquarters
- Femasys Announces Financial Results for Quarter Ended June 30, 2024 and Provides Corporate Update
- Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in Amsterdam
- Femasys Receives CE Mark Approval for Four of its Women’s Health Products Clearing the Path for the Company to Begin Commercialization Efforts in Europe
More ▼